Heron Therapeutics
HRTX
#7834
Rank
A$0.38 B
Marketcap
$2.52
Share price
3.27%
Change (1 day)
-4.09%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.87. In 2022 the company made an earnings per share (EPS) of -$2.76 an increase over its 2021 EPS that were of -$3.59.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-36.18%
2022-$2.76-23.11%
2021-$3.59-10%
2020-$3.99-0%
2019-$3.991.21%
2018-$3.95-32.7%
2017-$5.86-19.34%
2016-$7.2754.76%
2015-$4.701.73%
2014-$4.62-16.23%
2013-$5.5191.67%
2012-$2.88-31.45%
2011-$4.20-27.06%
2010-$5.75-43.75%
2009-$10.22-57.33%
2008-$23.96-82.92%
2007-$140.2820.61%
2006-$116.31175.76%
2005-$42.18-21.43%
2004-$53.68100%
2003-$26.84-38.24%
2002-$43.46161.54%
2001-$16.62-106.46%
2000$257.052051.55%
1999$11.95839.73%
1998$1.27-105.48%
1997-$23.22-88.16%
1996-$196.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.08-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.60 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.51-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.64 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA